Speaker

Professor Mark Febbraio is a National Health and Medical Research Council of Australia Investigator and the Head of the Cellular and Molecular Metabolism Laboratory within the Drug Discovery Program at Monash Institute of Pharmaceutical Sciences, Monash University Australia. He is the Founder and Chief Scientist of Celesta Therapeutics and a scientific advisor for Vitaleon Pharma. His research is focussed on understanding mechanisms associated with exercise, obesity, type 2 diabetes and cancer and his aim is to develop novel drugs to treat lifestyle related diseases. He has authored over 280 peer reviewed papers in leading journals and has over 55,000 career citations. Throughout his career, he has won many prestigious awards including the Australian Physiological Society (AuPS) AK McIntyre Prize (1999), the Kellion Award for the Australian Diabetes Society (2017), The Eureka Scientific Prize (2020), The GSK Award for Research Excellence (2020), The Endocrinology Society UK International Medal (2021) the Kirsten and Freddy Johansen Rigshospitalet International Award, Denmark (2022) and The AuPS Invited Lecture and Medal (2024).

« Go Back